A/RES/74/178 International cooperation to address and counter the world drug problem well-being among individuals, families and communities and reducing the adverse consequences of drug abuse for individuals and society as a whole; 59. Also recognizes the continued efforts to promote coordination and cooperation on drug-related matters within the United Nations system; 60. Calls upon the United Nations Office on Drugs and Crime, the Commission on Narcotic Drugs, the International Narcotics Control Board , the World Health Organization and other United Nations entities with pertinent technical and operational expertise, within their mandates, to continue to provide, upon request, advice and assistance to States that are reviewing and updating their drug po licies, in compliance with the three international drug control conventions, taking into account their national priorities and needs through, among other things, the promotion of the exchange of information and best practices on scientific evidence -based policies adopted by States; 61. Calls upon Member States to promote and strengthen the exchange of information and, as appropriate, drug-related criminal intelligence among law enforcement and border control agencies, including through the United Nations Office on Drugs and Crime multilateral portals and regional information centres and networks, and to promote joint investigations and coordinate operations, in conformity with national legislation, and training programmes at all levels, in order to identify, disrupt and dismantle organized criminal groups operating transnationally that are involved in any activities related to the illicit production of and trafficking in narcotic drugs and psychotropic substances and the diversion of their precursors and related money-laundering; 62. Reiterates the commitment of Member States to share relevant information with, as appropriate, and strengthen the capacity of the World Health Organization, the United Nations Office on Drugs and Crime, the International Narcoti cs Control Board and other relevant international and regional organizations to prioritize the review of the most prevalent, persistent and harmful new psychoactive substances and to facilitate informed scheduling decisions by the Commission on Narcotic Drugs; 63. Encourages Member States to fully support the efforts of the World Health Organization to review substances, within its mandate under the three international drug control conventions, particularly through its Expert Committee on Drug Dependence; 64. Also encourages Member States to enhance the capacity of law enforcement agencies to detect and identify new psychoactive substances and amphetamine-type stimulants, including methamphetamine, and promote cross border cooperation and information-sharing to prevent their abuse and diversion, including through the use of existing International Narcotics Control Board and United Nations Office on Drugs and Crime tools and projects; 65. Further encourages Member States to establish and strengthen partnerships and information exchange with industries, in particular with chemical and pharmaceutical industries and other relevant private sector entities, and encourage the use of the Guidelines for a Voluntary Code of Practice for the Chemical Industry, issued by the International Narcotics Control Board, and the Board ’s model memorandum of understanding between Governments and private sector partners, as and where appropriate, bearing in mind the important role that these industries can play in addressing and countering the world drug problem; 66. Calls upon Member States to commit themselves to implementing timely, scientific evidence-based control or regulatory measures within national legislative and administrative systems to tackle and manage the challenge of new psychoactive 14/23 19-22335

Select target paragraph3

Connect to a paragraph
Connect to an entity
Disable highlights
Add to table of contents